Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Multicentre Randomised Double-Blind Double-Dummy Active Comparator Controlled Parallel Group Study of COLAL PRED in the Treatment of Moderate Acute Ulcerative Colitis

The objective of this study is to compare safety and efficacy of COLAL PRED with prednisolone in patients diagnosed with moderate acute ulcerative colitis by the following: To determine the optimum dose ie the dose that demonstrates non-inferiority to conventional prednisolone in terms of efficacy with a significant reduction or absence of steroid-related adverse effects To investigate the clinical differences in response between 40 60 and 80 mg of COLAL PRED in terms of safety and efficacy

FieldValue
Modified
2019-08-28
Release Date
2018-03-06
Identifier
2f21367e-7750-44be-8077-faea7ebe3537
License
Public Access Level
Public